WO2023131811 - POLYCISTRONIC EXPRESSION OF GUT PEPTIDES
National phase entry:
Publication Number
WO/2023/131811
Publication Date
13.07.2023
International Application No.
PCT/IB2022/000815
International Filing Date
15.12.2022
Title **
[English]
POLYCISTRONIC EXPRESSION OF GUT PEPTIDES
[French]
EXPRESSION POLYCISTRONIQUE DE PEPTIDES INTESTINAUX
Applicants **
MEIRAGTX UK II LIMITED
Inventors
GUO, Xuecui
FORBES, Alexandria
Priority Data
63/361,399
15.12.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4467 | |
| EPO | Filing, Examination, Granting | 69429 | |
| Japan | Filing, Examination, Granting | 4251 | |
| South Korea | Filing, Examination, Granting | 6325 | |
| USA | Filing, Examination, Granting | 20940 |
Total:
105,412
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are monocistronic, bicistronic, and polycistronic expression constructs for the expression of gut peptides and pharmaceutical compositions comprising such expression constructs. Also provided are methods of using such expression constructs, for example, for inducing satiation in a subject in need thereof or for treating obesity in a subject in need thereof.[French]
L'invention concerne des constructions d'expression monocistroniques, bicistroniques et polycistroniques pour l'expression de peptides intestinaux et des compositions pharmaceutiques comprenant de telles constructions d'expression. L'invention concerne également des méthodes d'utilisation de telles constructions d'expression, par exemple, pour induire la satiété chez un sujet le nécessitant ou pour traiter l'obésité chez un sujet le nécessitant.